SULT1A1 (Minoxidil Sulfotransferase) Enzyme Booster Significantly Improves Response to Topical Minoxidil for Hair Regrowth

January 2022 in “ Journal of Cosmetic Dermatology ”

Rachita Dhurat, Sanober Burzin Daruwalla, Suraj Pai, Maja Kovacevic, John D. McCoy, Jerry Shapiro, Rod Sinclair, Sergio Vano-Galvan, Andy Goren

SULT1A1 minoxidil topical minoxidil hair regrowth hair loss enzyme booster Minoxidil Sulfotransferase Rogaine

TLDR Enzyme booster SULT1A1 greatly enhances hair regrowth with minoxidil.

A study involving multiple doctors and medical centers from around the world found that using an enzyme booster called SULT1A1 along with topical minoxidil significantly improved hair regrowth in individuals with hair loss. Boosting the SULT1A1 enzyme, responsible for metabolizing minoxidil, significantly improves the response to topical minoxidil for hair regrowth. Minoxidil is the only topical drug approved by the US FDA to regrow hair, but has a low efficacy rate, with only approximately 35% of subjects regrowing hair after 16 weeks of use in clinical trials. The study was not funded and study materials were provided at no cost by Applied Biology, Inc.

View this study on minerva-access.unimelb.edu.au →

Discuss this study in the Community →

Cited in this study

8 / 8 results

research Minoxidil Sulfotransferase Enzyme (SULT1A1) Genetic Variants Predict Response to Oral Minoxidil Treatment for Female Pattern Hair Loss

7 citations , January 2021 in “Journal of The European Academy of Dermatology and Venereology”

Genetic variants affect minoxidil hair loss treatment success.

research Novel Topical Booster Enhances Follicular Sulfotransferase Activity in Patients with Androgenetic Alopecia: A New Strategy to Improve Minoxidil Response

3 citations , December 2020 in “Journal of The European Academy of Dermatology and Venereology”

Topical booster improves hair loss treatment effectiveness.

research Novel 'After Minoxidil' Spray Improves Topical Minoxidil Compliance and Hair Style Manageability

1 citations , August 2020 in “Journal of Cosmetic Dermatology”

The "After Minoxidil" spray makes hair easier to style, less greasy, and encourages people to keep using the treatment.

research Characterization of Follicular Minoxidil Sulfotransferase Activity in a Cohort of Pattern Hair Loss Patients from the Indian Subcontinent

8 citations , October 2018 in “Dermatologic Therapy”

About 41% of Indian hair loss patients have low enzyme activity that affects hair loss treatment effectiveness, with men affected more than women. Testing for this can guide treatment.

research Clinical Utility and Validity of Minoxidil Response Testing in Androgenetic Alopecia

43 citations , January 2015 in “Dermatologic Therapy”

Minoxidil response testing helps treat hair loss effectively and safely.

research A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men

142 citations , November 2007 in “Journal of The American Academy of Dermatology”

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

research Minoxidil Sulfotransferase, a Marker of Human Keratinocyte Differentiation

16 citations , May 1992 in “Journal of Investigative Dermatology”

Minoxidil sulfotransferase is a marker of keratinocyte differentiation and may play a role in hair growth.

research Minoxidil Sulfate Is the Active Metabolite that Stimulates Hair Follicles

166 citations , November 1990 in “Journal of Investigative Dermatology”

Minoxidil sulfate stimulates hair growth.

9 / 9 results

research Hair Growth Therapy(ies) for Androgenetic Alopecia

June 1996 in “Archives of Dermatology”

Minoxidil, tretinoin, and finasteride may help hair regrowth in mild to moderate androgenetic alopecia.

research USE OF TOPICAL MINOXIDIL THERAPY FOR ANDROGENETIC ALOPECIA IN WOMEN

58 citations , October 1993 in “International Journal of Dermatology”

Minoxidil helps hair growth and reduces shedding in women.

research TREATMENT OF FEMALE ANDROGENETIC ALOPECIA WITH MINOXIDIL 2%

43 citations , November 1992 in “International Journal of Dermatology”

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

SULT1A1 (Minoxidil Sulfotransferase) Enzyme Booster Significantly Improves Response to Topical Minoxidil for Hair Regrowth

Cited in this study

research Minoxidil Sulfotransferase Enzyme (SULT1A1) Genetic Variants Predict Response to Oral Minoxidil Treatment for Female Pattern Hair Loss

research Novel Topical Booster Enhances Follicular Sulfotransferase Activity in Patients with Androgenetic Alopecia: A New Strategy to Improve Minoxidil Response

research Novel 'After Minoxidil' Spray Improves Topical Minoxidil Compliance and Hair Style Manageability

research Characterization of Follicular Minoxidil Sulfotransferase Activity in a Cohort of Pattern Hair Loss Patients from the Indian Subcontinent

research Clinical Utility and Validity of Minoxidil Response Testing in Androgenetic Alopecia

research A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men

research Minoxidil Sulfotransferase, a Marker of Human Keratinocyte Differentiation

research Minoxidil Sulfate Is the Active Metabolite that Stimulates Hair Follicles

Related

research Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil

research A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss

research Oral Minoxidil Improves Background Hair Thickness in Lichen Planopilaris

research Efficacy of Systemic Minoxidil and Tofacitinib Combination in Treatment-Resistant Alopecia Universalis

research Pustular Dermatosis of the Scalp Due to Topical Minoxidil 5%

research Scalp Psoriasiform Contact Dermatitis with Acute Telogen Effluvium Due to Topical Minoxidil Treatment

research Hair Growth Therapy(ies) for Androgenetic Alopecia

research USE OF TOPICAL MINOXIDIL THERAPY FOR ANDROGENETIC ALOPECIA IN WOMEN

research TREATMENT OF FEMALE ANDROGENETIC ALOPECIA WITH MINOXIDIL 2%